Sort   by:  
 Page size 
UnknownCHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
Not available
S-EPMC8989306 | biostudies-literature
UnknownNovel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge.
Not available
S-EPMC7224506 | biostudies-literature
UnknownAdenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.
Not available
S-EPMC3189219 | biostudies-literature
UnknownIMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
Not available
S-EPMC7299375 | biostudies-literature
UnknownMosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Not available
S-EPMC4957371 | biostudies-literature
UnknownHuman responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
Not available
S-EPMC11825025 | biostudies-literature
UnknownIMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
Not available
S-EPMC8378721 | biostudies-literature
UnknownAdenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.
Not available
S-EPMC3189181 | biostudies-literature
UnknownDNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
Not available
S-EPMC3573028 | biostudies-literature
UnknownA three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naive adults.
Not available
S-EPMC8425539 | biostudies-literature
Sort   by:  
 Page size